FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with <i>FGFR2</i> Fusion Status and Immune Signatures
Vishwajith Sridharan(Massachusetts General Hospital), Lipika Goyal(Massachusetts General Hospital)
Cited by 14
Related Papers
Polyclonal Secondary <i>FGFR2</i> Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
|Cancer Discovery|2016|539
Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer
|British Journal of Cancer|2016|84